热门资讯> 正文
2025-11-06 21:37
Whitehawk Therapeutics (NASDAQ: WHWK) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $0.07 by 488.06 percent. This is a 43.48 percent increase over losses of $(0.46) per share from the same period last year.